台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    60.9
  • 漲跌
    ▲1.2
  • 漲幅
    +2.01%
  • 成交量
    158
  • 產業
    上櫃 生技醫療類股
  • 69人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
易威 (1799)籌碼相關-元大-蘆洲中正 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-蘆洲中正 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/15161.2000.0061.0016160.16%
2025/01/1400.00162.1062.90-1621-0.16%
2025/01/13167.0000.0062.8016270.16%
2025/01/07164.5000.0062.8016220.16%
2024/12/31164.5000.0064.3016690.15%
2024/12/3000.00266.6066.70-2692-0.29%
2024/12/27262.50262.1063.3006970.00%
2024/12/26268.60166.6066.6016920.14%
2024/12/2300.00264.2066.40-2680-0.29%
2024/12/2000.00161.3060.40-1684-0.15%
2024/12/19163.70161.7062.7006950.00%
2024/12/16455.78155.9054.5036790.44%
2024/12/06164.8000.0064.3016510.15%
2024/12/0400.00166.7067.00-1655-0.15%
2024/12/0300.00367.4067.80-3662-0.45%
2024/11/29164.90166.1067.9006710.00%
2024/11/27168.4000.0066.5016770.15%
2024/11/2500.00173.8071.90-1681-0.15%
2024/11/22172.6000.0073.0016720.15%
2024/11/2000.00568.5467.40-5666-0.75%
2024/11/1900.00467.2567.40-4667-0.60%
2024/11/18167.30168.9067.0006760.00%
2024/11/15171.8000.0066.0016780.15%
2024/11/1400.00164.4069.00-1670-0.15%
2024/11/1300.00164.7564.00-1652-0.15%
2024/11/12165.70166.0070.0006320.00%
2024/11/07185.70287.1086.10-1620-0.16%
2024/11/0600.00485.4085.20-4634-0.63%
2024/11/0500.00485.4084.90-4636-0.63%
2024/11/0400.00189.8091.80-1637-0.16%
2024/10/3000.00496.0093.80-4670-0.60%
2024/10/29395.4000.0096.4036790.44%
2024/10/252102.501104.50100.0016870.15%
2024/10/242104.001101.50102.5016970.14%
2024/10/221104.502107.00107.00-1726-0.14%
2024/10/2100.001105.50105.50-1736-0.14%
2024/10/187112.2900.00110.0077680.91%
2024/10/1600.004117.13117.00-4799-0.50%
2024/10/152118.0000.00117.0028110.25%
2024/10/091130.001121.00119.0008380.00%
2024/10/082124.001118.50126.0018390.12%
2024/10/0700.002.5115.15116.50-2.5830-0.30%
2024/10/04188.902.5106.50106.50-1.5813-0.18%
2024/10/01498.5500.0097.2047870.51%
2024/09/302108.0000.00108.0027770.26%
2024/09/271120.0000.00120.0017960.13%
2024/09/261133.0000.00133.0017850.13%
2024/09/2300.001166.50158.00-1794-0.13%
2024/09/162175.0000.00175.5027800.26%
2024/09/131183.5000.00178.0017790.13%
2024/08/301218.001220.00216.0007920.00%
2024/08/281214.5000.00210.0017880.13%
2024/08/1900.0016197.16201.50-16820-1.95%
2024/08/121199.0000.00198.0018350.12%
2024/08/091204.0000.00203.5018240.12%
2024/08/061178.0000.00171.0017770.13%
2024/08/0500.002175.00180.00-2768-0.26%
2024/08/0200.001185.00177.50-1749-0.13%
2024/07/239160.067159.57160.0026850.29%
2024/07/226164.0000.00164.0066670.90%
2024/07/196177.002186.50182.0046500.61%
2024/07/182197.0000.00196.5026110.33%
2024/07/172176.7500.00191.0025890.34%
2024/07/1200.002158.50162.00-2544-0.37%
2024/07/092138.0000.00139.0024990.40%
2024/07/0400.001124.00126.00-1477-0.21%
2024/07/0311126.4500.00124.50114742.32%
2024/07/021135.5000.00138.0014460.22%
2024/07/012134.5000.00137.5024350.46%
2024/06/284128.002130.00130.0024130.48%
2024/06/193101.8300.00101.5033740.80%
2024/06/181104.0000.00104.5013640.27%
2024/06/172104.001105.50108.0013530.28%
2024/05/231100.501100.50100.5002860.00%
2024/04/2200.003064.9464.50-30253-11.81%
2024/04/0800.001068.0168.90-10251-3.98%
2024/04/0100.00970.5069.90-9247-3.63%
2024/03/2600.00170.0069.30-1241-0.41%
2024/03/2200.00062.5064.300230-0.02%
2024/03/07163.00067.5064.5012090.46%
2024/03/0400.00258.3560.20-2193-1.03%
2024/02/1500.00155.5055.50-1177-0.56%
2024/01/3100.002.743.2645.60-2.7149-1.80%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音